
Early CAR-T Results Point to a New Path for Long-Term HIV Control
A small clinical study suggests engineered immune cells may help some people with HIV maintain undetectable virus levels without ongoing medication, raising the prospect of longer-lasting control beyond daily antiretroir
- Two trial participants maintained undetectable HIV without ongoing medication after a single CAR-T infusion.
- The study is early and small, focused on safety and feasibility rather than broad efficacy.